Safety and Efficacy of IZN-6N4 Oral Rinse for the Prevention of Oral Mucositis in Patients With Head and Neck Cancer
NCT01400620
·
clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
110
Enrollment
INDUSTRY
Sponsor class
Conditions
Oral Mucositis
Interventions
DRUG:
IZN-6N4
Sponsor
Izun Pharma Ltd